Systemic lupus erythematosus: Old and new susceptibility genes versus clinical manifestations

Current Genomics

Volumn 15, Issue 1, 2014, Pages 52-65

  De Azevedo Silva J ^a   Addobbati, C ^a   Sandrin Garcia, P ^a   Crovella, S ^a  

^a FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

Author keywords

Autoimmunity; B cells; Clinical manifestations; DSBs; IFN; SLE; SNPs; T cells

Indexed keywords

CD28 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4 ANTIBODY; INTERFERON REGULATORY FACTOR 5; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22; OX40 LIGAND; PROGRAMMED DEATH 1 LIGAND 1; PROLACTIN; STAT4 PROTEIN; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; VITAMIN D RECEPTOR; XRCC1 PROTEIN; XRCC3 PROTEIN; XRCC4 PROTEIN;

CELL PROLIFERATION; DISEASE SEVERITY; DNA REPAIR; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; HUMAN; IMMUNE RESPONSE; NONHUMAN; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVIEW; SEQUENCE HOMOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE;

EID: 84896331788     PISSN: 13892029     EISSN: 18755488     Source Type: Journal    
DOI: 10.2174/138920291501140306113715     Document Type: Review

References (159)

1. Guerra, S.G.; Vyse, T.J.; Cunninghame Graham, D. S. The Genetics of Lupus: A Functional Perspective. Arthritis Res. Tther., 2012, 14, 211.
2. Chai, H.C.; Phipps, M.E.; Chua, K.H. Genetic Risk Factors of Systemic Lupus Erythematosus in the Malaysian Population: a Minireview. Clin. Dev. Immunol., 2012, 2012, 963730.
3. Rahman, A.; Isenberg, D.A. Systemic Lupus Erythematosus. 2008, 358(9), 929-939.
4. Hochberg, M.C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum., 1997, 9, 1725.
5. Murphy, G.; Isenberg, D. Effect of Gender on Clinical Presentation in Systemic Lupus Erythematosus. Rheumatology (Oxford, England), 2013. DOI:10.1093/rheumatology/ket160
6. Tsokos, G. C. Systemic Lupus Erythematosus. N. Engl. J. Med., 2011, 365, 2110-21.
7. Criswell, L.A. The Genetic Contribution to Systemic Lupus Erythematosus. Bull. NYU. Hosp. Jt. Dis., 2008, 3, 176-83.
8. Rhodes, K. A; Andrew, E. M.; Newton, D. J.; Tramonti, D.; Carding, S. R. A Subset of IL-10-producing Gammadelta T Cells Protect the Liver from Listeria-elicited, CD8(+) T Cell-mediated Injury. Eur. J. Immunol., 2008, 38, 2274-83.
9. Yanaba, K.; Bouaziz, J. D.; Matsushita, T.; Tsubata, T.; Tedder, T. F. The Development and Function of Regulatory B Cells Expressing IL-10 (B10 Cells) Requires Antigen Receptor Diversity and TLR Signals. J. Immunol., 2009, 182, 7459-72.
10. Malefyt, D. W.; Haanen, J.; Spits, H.; Koncarolo, M.; te Velde, A.; Figdor, C.; Johnson, K.; Kastelein, R.; Yssel, H.; Vries, J. E.; Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigenspecific human T cell proliferation by diminishing the antigenpresenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J. Exp. Med., 1991, 174, 915-24.
11. Fiorentino, D. F.; Bond, M. W.; Mosmann, T. R. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. Med., 1989, 170, 2081-95.
12. Rousset, F.; Garcia, E.; Defrance, T.; Péronne, C.; Vezzio, N.; Hsu, D. H.; Kastelein, R.; Moore, K. W.; Banchereau, J. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc. Natl. Acad. Sci. U.S.A., 1992, 89, 1890-93.
13. Eskdale, J.; Gallagher, G. A Polymorphic Dinucleotide Repeat in the Human IL-10 Promoter. Immunogenetics, 1995, 42, 444-5.
14. Eskdale, J.; Kube, D.; Gallagher, G. A Second Polymorphic Dinucleotide Repeat in the 5' Flanking Region of the Human IL10 Gene. Immunogenetics, 1996, 45, 82-83.
15. Kube, D.; Platzer, C.; von Knethen, A.; Straub, H.; Bohlen, H.; Hafner, M.; Tesch, H. Isolation of the human interleukin 10 promoter. Characterization of the promoter activity in Burkitt's lymphoma cell lines. Cytokine, 1995, 7, 1-7.
16. Lim, S.; Crawley, E.; Woo, P.; Barnes, P. J. Haplotype Associated with Low Interleukin-10 Production in Patients with Severe Asthma. Lancet, 1998, 352, 113.
17. Turner, D. M.; Williams, D. M.; Sankaran, D.; Lazarus, M.; Sinnott, P. J.; Hutchinson, H. I. An Investigation of Polymorphism in the Interleukin-10 Gene Promoter. Immunogenetics, 1997, 24, 1-8.
18. D'Alfonso, S.; Rampi, M.; Bocchio, D.; Colombo, G.; Scorza-Smeraldi, R.; Momigliano-Richardi, P. Systemic Lupus Erythematosus Candidate Genes in the Italian Population: Evidence for a Significant Association with Interleukin-10. Arthritis Tther., 2000, 43, 120-8.
19. Sobkowiak, A.; Lianeri, M.; Wudarski, M.; Łacki, J. K.; Jagodziński, P. P. Genetic Variation in the Interleukin-10 Gene Promoter in Polish Patients with Systemic Lupus Erythematosus. Rheumatol. Int., 2009, 29, 921-5.
20. Rosado, S.; Rua-Figueroa, I.; Vargas, J. a; Garcia-Laorden, M. I.; Losada-Fernandez, I.; Martin-Donaire, T.; Perez-Chacon, G.; Rodriguez-Gallego, C.; Naranjo-Hernandez, a; Ojeda-Bruno, S.; Citores, M.J.; Perez-Aciego, P. Interleukin-10 Promoter Polymorphisms in Patients with Systemic Lupus Erythematosus from the Canary Islands. Int. J. Immunogenetics, 2008, 35, 235-42.
21. Chen, J. Y.; Wang, C. M.; Lu, S. C.; Chou, Y. H.; Luo, S. F. Association of Apoptosis-related Microsatellite Polymorphisms on Chromosome 1q in Taiwanese Systemic Lupus Erythematosus Patients. Clin. Exp. Immunol., 2006, 143, 281-7.
22. Chong, W.P.; Ip, W.K.; Wong, W.H.-S.; Lau, C.S.; Chan, T.M.; Lau, Y.L. Association of Interleukin-10 Promoter Polymorphisms with Systemic Lupus Erythematosus. Genes Immun., 2004, 5, 484-92.
23. Khoa, P. D.; Sugiyama, T.; Yokochi, T. Polymorphism of Interleukin-10 Promoter and Tumor Necrosis Factor Receptor II in Vietnamese Patients with Systemic Lupus Erythematosus. Clin. Rheumat., 2005, 24, 11-3.
24. Suárez, A.; López, P.; Mozo, L.; Gutiérrez, C. Differential Effect of IL10 and TNF{alpha} Genotypes on Determining Susceptibility to Discoid and Systemic Lupus Erythematosus. Ann. Rheum. Dis., 2005, 64, 1605-10.
25. Rood, M. J.; Keijsers, V.; van der Linden, M. W.; Tong, T. Q.; Borggreve, S. E.; Verweij, C. L.; Breedveld, F. C.; Huizinga, T. W. Neuropsychiatric Systemic Lupus Erythematosus Is Associated with Imbalance in Interleukin 10 Promoter Haplotypes. Ann. Rheum. Dis., 1999, 58, 85-9.
26. Zhu, L. J.; Liu, Z. H.; Zeng, C. H.; Chen, Z. H.; Yu, C.; Li, L. S. Association of Interleukin-10 Gene-592 A/C Polymorphism with the Clinical and Pathological Diversity of Lupus Nephritis. Clin. Exp. Rheum., 2005, 23, 854-60.
27. Schotte, H.; Gaubitz, M.; Willeke, P.; Tidow, N.; Assmann, G.; Domschke, W.; Schlüter, B. Interleukin-10 Promoter Microsatellite Polymorphisms in Systemic Lupus Erythematosus: Association with the anti-Sm Immune Response. Rheumatol., 2004, 43, 1357-63.
28. Khoury, S. J.; Sayegh, M. H. The Roles of the New Negative T Cell Costimulatory Pathways in Regulating Autoimmunity. Immunity, 2004, 20, 529-538.
29. Francisco, L. M.; Sage, P. T.; Sharpe, A. H. The PD-1 pathway in tolerance and autoimmunity. Immunol. Rev., 2010, 236, 219-42.
30. Prokunina, L.; Castillejo-López, C.; Oberg, F.; Gunnarsson, I.; Berg, L.; Magnusson, V.; Brookes, A.J.; Tentler, D.; Kristjansdóttir, H.; Gröndal, G.; Bolstad, A.I.; Svenungsson, E.; Lundberg, I.; Sturfelt, G.; Jönssen, A.; Truedsson, L.; Lima, G.; Alcocer-Varela, J.; Jonsson, R.; Gyllensten, U. B.; Harley, J.B.; Alarcón-Segovia, D.; Steinsson, K., Alarcón-Riquelme, M.E. A Regulatory Polymorphism in PDCD1 Is Associated with Susceptibility to Systemic Lupus Erythematosus in Humans. Nature Genet., 2002, 32, 666-9.
31. Bertsias, G.K.; Nakou, M.; Choulaki, C.; Raptopoulou, A.; Papadimitraki, E.; Goulielmos, G.; Kritikos, H.; Sidiropoulos, P.; Tzardi, M.; Kardassis, D.; Mamalaki, C.; Boumpas, D.T. Genetic, Immunologic, and Immunohistochemical Analysis of the Programmed Death 1/programmed Death Ligand 1 Pathway in Human Systemic Lupus Erythematosus. Arthr. Rheum., 2009, 60, 207-18.
32. Ferreiros-Vidal, I.; Gomez-Reino, J.J.; Barros, F.; Carracedo, A.; Carreira, P.; Gonzalez-Escribano, F.; Liz, M.; Martin, J.; Ordi, J.; Vicario, J.L.; Gonzalez, A. Association of PDCD1 with Susceptibility to Systemic Lupus Erythematosus: Evidence of Populationspecific Effects. Arthr. Rheum., 2004, 50, 2590-7.
33. Johansson, M.; Arlestig, L.; Möller, B.; Rantapää-Dahlqvist, S. Association of a PDCD1 Polymorphism with Renal Manifestations in Systemic Lupus Erythematosus. Arthr. Rheum., 2005, 52, 1665-9.
34. Prokunina, L.; Gunnarsson, I.; Sturfelt, G.; Truedsson, L.; Seligman, V. A; Olson, J. L.; Seldin, M. F.; Criswell, L. A; Alarcón-Riquelme, M. E. The Systemic Lupus Erythematosus-associated PDCD1 Polymorphism PD1.3A in Lupus Nephritis. Arthr. Rheum., 2004, 50, 327-8.
35. Wang, S. C.; Chen, Y. J.; Ou, T. T.; Wu, C. C.; Tsai, W. C.; Liu, H. W.; Yen, J. H. Programmed Death-1 Gene Polymorphisms in Patients with Systemic Lupus Erythematosus in Taiwan. J. Clin. Immunol., 2006, 26, 506-11.
36. Mostowska, M.; Wudarski, M.; Chwalińska-Sadowska, H.; Jagodziński, P. P. The Programmed Cell Death 1 Gene 7209 C>T Polymorphism Is Associated with the Risk of Systemic Lupus Erythematosus in the Polish Population. Clin. Exp. Rheum., 2008, 26, 457-60.
37. Shelly, S.; Boaz, M.; Orbach, H. Prolactin and autoimmunity. Autoimmun. Rev., 2012, a465-a470.
38. Stevens, A.; Ray, D.; Alansari, A.; Hajeer, A.; Thomson, W.; Donn, R.; Ollier, W. E.; Worthington, J. D. J.; Davis, J. R. Characterization of a Prolactin Gene Polymorphism and Its Associations with Systemic Lupus Erythematosus. Arthritis Rheum., 2001, 2358-66.
39. Montoya-Díaz, E.; Cervera-Castillo, H.; Chávez-Sánchez, L.; Legorreta-Haquet, M. V.; Sánchez-González, L.; Chávez-Rueda, K.; Blanco-Favela, F. Prolactin Promoter Polymorphism (-1149 G/T) Is Associated with anti-DNA Antibodies in Mexican Patients with Systemic Lupus Erythematosus. Immunol. Invest., 2011, 40, 614-26.
40. Cloutier, J. F.; Veillette, A. Cooperative Inhibition of T-cell Antigen Receptor Signaling by a Complex Between a Kinase and a Phosphatase. J. Exp. Med., 1999, 189, 111-21.
41. Wu, J.; Katrekar, A.; Honigberg, L. a; Smith, A. M.; Conn, M. T.; Tang, J.; Jeffery, D.; Mortara, K.; Sampang, J.; Williams, S. R; Buggy, J.; Clark, J. M. Identification of Substrates of Human Protein-tyrosine Phosphatase PTPN22. J. Biol. Chem., 2006, 281, 11002-10.
42. Ghose, R.; Shekhtman, A; Goger, M. J.; Ji, H.; Cowburn, D. A Novel, Specific Interaction Involving the Csk SH3 Domain and Its Natural Ligand. Nat. Struc. Biol., 2001, 8, 998-1004.
43. Manjarrez-Orduño, N.; Marasco, E.; Chung, S. A.; Katz, M. S.; Kiridly, J. F.; Simpfendorfer, K. R.; Freudenberg, J.; Ballard, D. H.; Nashi, E.; Hopkins, T. J.; Cunninghame Graham, D. S.; Lee, A. T.; Coenen, M. J.; Franke, B.; Swinkels, D. W.; Graham, R. R.; Kimberly, R. P.; Gaffney, P. M.; Vyse, T. J.; Behrens, T. W.; Criswell, L. A.; Diamond, B.; Gregersen, P. K. CSK regulatory polymorphism is associated with systemic lupus erythematosus and influences B-cell signaling and activation. Nat. Genet., 2012, 11, 1227-30.
44. Vang, T.; Congia, M.; Macis, M. D.; Musumeci, L.; Orrú, V.; Zavattari, P.; Nika, K.; Tautz, L.; Taskén, K.; Cucca, F.; Mustelin, T., Bottini, N. Autoimmune-associated Lymphoid Tyrosine Phosphatase Is a Gain-of-function Variant. Nat. Genet., 2005, 1317-9.
45. Reddy, M. V.; Johansson, M.; Sturfelt, G.; Jönsen, A; Gunnarsson, I.; Svenungsson, E.; Rantapää-Dahlqvist, S.; Alarcón-Riquelme, M. E. The R620W C/T Polymorphism of the Gene PTPN22 Is Associated with SLE Independently of the Association of PDCD1. Genes Immun., 2005, 6, 658-62.
46. Orozco, G.; Sánchez, E.; González-Gay, M. A; López-Nevot, M. A; Torres, B.; Cáliz, R.; Ortego-Centeno, N.; Jiménez-Alonso, J.; Pascual-Salcedo, D.; Balsa, A.; de Pablo, R.; Nuñez-Roldan, A.; González-Escribano, M.F.; Martín, J. Association of a Functional Single-nucleotide Polymorphism of PTPN22, Encoding Lymphoid Protein Phosphatase, with Rheumatoid Arthritis and Systemic Lupus Erythematosus. Arthritis Rheum., 2005, 52, 219-24.
47. Eliopoulos, E.; Zervou, M.I.; Andreou, A.; Dimopoulou, K.; Cosmidis, N.; Voloudakis, G.; Mysirlaki, H.; Vazgiourakis, V.; Sidiropoulos, P.; Niewold, T. B.; Boumpas, D. T.; Goulielmos, G. N. Association of the PTPN22 R620W polymorphism with increased risk for SLE in the genetically homogeneous population of Crete. Lupus, 2011, 20, 501-6.
48. Piotrowski, P.; Lianeri, M.; Wudarski, M.; Lacki, J. K.; Jagodziński, P. P. Contribution of the R620W Polymorphism of Protein Tyrosine Phosphatase Non-receptor 22 to Systemic Lupus Erythematosus in Poland. Clin. Exp. Rheumatol., 2008, 26, 1099-102.
49. Moez, P.; Soliman, E. Association of PTPN22 Gene Polymorphism and Systemic Lupus Erythematosus in a Cohort of Egyptian Patients: Impact on Clinical and Laboratory Results. Rheumatol. Int., 2012, 32, 2753-8.
50. Kyogoku, C.; Langefeld, C. D.; Ortmann, W. A; Lee, A.; Selby, S.; Carlton, V. E.; Chang, M.; Ramos, P.; Baechler, E. C.; Batliwalla, F. M.; Novitzke J.; Williams, A. H.; Gillett, C.; Rodine, P.; Graham, R. R.; Ardlie, K. G.; Gaffney, P. M.; Moser, K. L.; Petri, M.; Begovich, A. B.; Gregersen, P. K.; Behrens, T. W. Genetic Association of the R620W Polymorphism of Protein Tyrosine Phosphatase PTPN22 with Human SLE. Am. J. Hum. Genet., 2004, 75, 504-7.
51. Gomez, L. M.; Anaya, J. M.; Gonzalez, C. I.; Pineda-Tamayo, R.; Otero, W.; Arango, A; Martín, J. PTPN22 C1858T Polymorphism in Colombian Patients with Autoimmune Diseases. Genes Immun., 2005, 6, 628-31.
52. Orrú, V.; Tsai, S. J.; Rueda, B.; Fiorillo, E.; Stanford, S. M.; Dasgupta, J.; Hartiala, J.; Zhao, L.; Ortego-Centeno, N.; D'Alfonso, S.; Italian Collaborative Group; Arnett, F. C.; Wu, H.; Gonzalez-Gay, M. A.; Tsao, B. P.; Pons-Estel, B.; Alarcon-Riquelme, M. E.; He, Y.; Zhang, Z. Y.; Allayee, H.; Chen, X. S.; Martin, J.; Bottini, N. A Loss-of-function Variant of PTPN22 Is Associated with Reduced Risk of Systemic Lupus Erythematosus. Hum. Mol. Genet. 2009, 18, 569-79.
53. Siggs, O. M.; Miosge, L. A; Yates, A. L.; Kucharska, E. M.; Sheahan, D.; Brdicka, T.; Weiss, A.; Liston, A.; Goodnow, C. C. Opposing Functions of the T Cell Receptor Kinase ZAP-70 in Immunity and Tolerance Differentially Titrate in Response to Nucleotide Substitutions. Immunity 2007, 27, 912-26.
54. Gregersen, P. K. Gaining insite into PTPN22 and autoimmunity. Nat. Genet., 2005, 22; 1300-13002.
55. Vang, T.; Congia, M.; Macis, M. D.; Musumecil, L.; Orru, V.; Zavattari, P.; Nika, K.; Tautz, L.; Taskén, K.; Cucca, F.; Mustelin, T.; Bottini, N. Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant. Nat. Gen., 2005, 12, 1317-19.
56. Zhang, J.; Zahir, N.; Jiang, Q.; Miliotis, H.; Heyraud, S.; Meng, X.; Dong, B.; Xie, G.; Qiu, F.; Hao, Z.; McCulloch, C. A.; Keystone, E. C.; Peterson, A. C.; Siminovitch, K. A. The autoimmune disease-associated PTPN22 variant promotes calpain-mediated Lyp/Pep degradation associated with lymphocyte and dendritic cell hyperresponsiveness. Nat. Genet., 2011, 9, 902-907.
57. Dai, X.; James, R. G.; Habib, T.; Singh, S.; Jackson, S.; Khim, S.; Moon, R. T.; Liggitt, D.; Wolf-Yadlin, A.; Buckner, J.H.; Rawlings, D.J. A disease-associated PTPN22 variant promotes systemic autoimmunity in murine models. J. Clin. Invest., 2013, 5, 2024-2036.
58. Peterson, E. J.; Woods, M. L.; Dmowski, S. A; Derimanov, G.; Jordan, M. S.; Wu, J. N.; Myung, P. S.; Liu, Q. H.; Pribila, J. T.; Freedman, B. D.; Shimizu, Y.; Koretzky, G. A. Coupling of the TCR to Integrin Activation by Slap-130/Fyb. Science, 2001, 293, 2263-5.
59. Griffiths, E. K.; Krawczyk, C.; Kong, Y. Y.; Raab, M.; Hyduk, S. J.; Bouchard, D.; Chan, V. S.; Kozieradzki, I.; Oliveira-Dos-Santos, A J.; Wakeham, A; Ohashi, P. S.; Cybulsky, M. I.; Rudd, C. E. Penninger JM. Positive Regulation of T Cell Activation and Integrin Adhesion by the Adapter Fyb/Slap. Science, 2001, 293, 2260-3.
60. Sandrin-Garcia, P.; Junta, C. M.; Fachin, A. L.; Mello, S. S.; Baião, A. M.; Rassi, D. M.; Ferreira, M. C.; Trevisan, G. L.; Sakamoto-Hojo, E. T.; Louzada-Júnior, P.; Passos, G. A.; Donadi, E. A. Shared and Unique Gene Expression in Systemic Lupus Erythematosus Depending on Disease activity. Ann. NY Acad. Sci., 2009, 493-500.
61. Addobbati, C.; Brandão, L. A.; Guimarães, R. L.; Pancotto, J. A.; Donadi, E. A.; Crovella, S.; Segat, L.; Sandrin-Garcia, P. FYB Gene Polymorphisms Are Associated with Susceptibility for Systemic Lupus Erythemathosus (SLE). Hum. Immunol., 2013, 74, 1009-14.
62. Ito, T.; Wang, Y. H.; Duramad, O.; Hori, T.; Delespesse, G. J.; Watanabe, N.; Qin, F. X.; Yao, Z.; Cao, W.; Liu, Y. J. TSLPactivated Dendritic Cells Induce an Inflammatory T Helper Type 2 Cell Response Through OX40 Ligand. J. Exp. Med., 2005, 202, 1213-23.
63. Linton, P. J.; Bautista, B.; Biederman, E.; Bradley, E. S.; Harbertson, J.; Kondrack, R. M.; Padrick, R. C.; Bradley, L. M. Costimulation via OX40L Expressed by B Cells Is Sufficient to Determine the Extent of Primary CD4 Cell Expansion and Th2 Cytokine Secretion in Vivo. J. Exp. Med., 2003, 197, 875-83.
64. Godfrey, W. R.; Fagnoni, F. F.; Harara, M. A.; Buck, D.; Engleman, E. G. Identification of a human OX-40 ligand, a costimulator of CD4+ T cells with homology to tumor necrosis factor. J. Exp. Med., 1994, 180, 757-62.
65. Chang, Y. K.; Yang, W.; Zhao, M.; Mok, C. C.; Chan, T. M.; Wong, R. W. S.; Lee, K. W.; Mok, M. Y.; Wong, S. N.; Ng, I. O.; Lee, T. L.; Ho, M. H.; Lee, P. P.; Wong, W. H.; Lau, C. S.; Sham, P. C.; Lau, Y. L. Association of BANK1 and TNFSF4 with Systemic Lupus Erythematosus in Hong Kong Chinese. Genes Immun., 2009, 10, 414-20.
66. Zhou, X.; Lu, X.; Nath, S. K.; Lv, J.; Zhu, S.; Yang, H.; Qin, L.; Zhao, M.; Su, Y.; Shen, N.; Li, Z. G.; Zhang, H.; International Consortium on the Genetics of Systemic Lupus Erythematosus. Gene-gene Interaction of BLK, TNFSF4, TRAF1, TNFAIP3, and REL in Systemic Lupus Erythematosus. Arthritis Rheum., 2012, 64, 222-31.
67. Han, J. W.; Zheng, H. F.; Cui, Y.; Sun, L. D.; Ye, D. Q.; Hu, Z.; Xu, J. H.; Cai, Z. M.; Huang, W.; Zhao, G. P.; Xie, H. F.; Fang, H.; Lu, Q. J.; Xu, J. H.; Li, X. P.; Pan, Y. F.; Deng, D. Q.; Zeng, F. Q.; Ye, Z. Z.; Zhang, X. Y.; Wang, Q. W.; Hao, F.; Ma, L.; Zuo, X. B.; Zhou, F. S.; Du, W. H.; Cheng, Y. L.; Yang, J. Q.; Shen, S. K.; Li, J.; Sheng, Y. J.; Zuo, X. X.; Zhu, W. F.; Gao, F.; Zhang, P. L.; Guo, Q.; Li, B.; Gao, M.; Xiao, F. L.; Quan, C.; Zhang, C.; Zhang, Z.; Zhu, K. J.; Li, Y.; Hu, D. Y.; Lu, W. S.; Huang, J. L.; Liu, S. X.; Li, H.; Ren, Y. Q.; Wang, Z. X.; Yang, C. J.; Wang, P. G.; Zhou, W. M.; Lv, Y. M.; Zhang, A. P.; Zhang, S. Q.; Lin, D.; Li, Y.; Low, H. Q.; Shen, M.; Zhai, Z. F.; Wang, Y.; Zhang, F. Y.; Yang, S.; Liu, J. J.; Zhang, X. J. Genome-wide Association Study in a Chinese Han Population Identifies Nine New Susceptibility Loci for Systemic Lupus Erythematosus. Nature Genet., 2009, 41, 1234-7.
68. Yang, W.; Shen, N.; Ye, D. Q.; Liu, Q.; Zhang, Y.; Qian, X.-X.; Hirankarn, N.; Ying, D.; Pan, H. F.; Mok, C. C.; Chan, T. M.; Wong, R. W.; Lee, K. W.; Mok, M. Y.; Wong, S. N.; Leung, A. M.; Li, X. P.; Avihingsanon, Y.; Wong, C. M.; Lee, T. L.; Ho, M. H.; Lee, P. P.; Chang, Y. K.; Li, P. H.; Li, R. J.; Zhang, L.; Wong, W. H.; Ng, I. O.; Lau, C. S.; Sham, P. C.; Lau, Y. L.; Asian Lupus Genetics Consortium. Genome-wide Association Study in Asian Populations Identifies Variants in ETS1 and WDFY4 Associated with Systemic Lupus Erythematosus. PLoS Genet., 2010, 6, e1000841.
69. Zhang, S. Q.; Han, J. W.; Sun, L. D.; Lu, W. S.; Yin, X. Y.; Zhang, X. J.; Yang, S. A Single-nucleotide Polymorphism of the TNFSF4 Gene Is Associated with Systemic Lupus Erythematosus in Chinese Han Population. Rheum. Int., 2011, 31, 227-31.
70. Gateva, V.; Sandling, J. K.; Hom, G.; Taylor, K. E.; Chung, S. A.; Sun, X.; Ortmann, W.; Kosoy, R.; Ferreira, R. C.; Nordmark, Gunnarsson, I.; Svenungsson, E.; Padyukov, L.; Sturfelt, G.; Jönsen, A.; Bengtsson, A.A.; Rantapää-Dahlqvist, S.; Baechler, E.C.; Brown, E.E.; Alarcón, G.S.; Edberg, J.C.; Ramsey-Goldman, R.; McGwin, G. Jr.; Reveille, J.D.; Vilá, L.M.; Kimberly, R.P.; Manzi, S.; Petri, M.A.; Lee, A.; Gregersen, P.K.; Seldin, M.F.; Rönnblom, L.; Criswell, L.A.; Syvänen, A.C.; Behrens, T.W.; Graham, R.R. A Large-scale Replication Study Identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as Risk Loci for Systemic Lupus Erythematosus. Nat. Genet., 2009, 41, 1228-33.
71. Cunninghame Graham, D. S.; Graham, R. R.; Manku, H.; Wong, A. K.; Whittaker, J. C.; Gaffney, P. M.; Moser, K. L.; Rioux, J. D.; Altshuler, D.; Behrens, T. W.; Vyse, T.J. Polymorphism at the TNF Superfamily Gene TNFSF4 Confers Susceptibility to Systemic Lupus Erythematosus. Nat. Gen., 2008, 40, 83-9.
72. Sánchez, E.; Comeau, M. E.; Freedman, B. I.; Kelly, J. A.; Kaufman, K. M.; Langefeld, C. D.; Brown, E. E.; Alarcón, G. S.; Kimberly, R. P.; Edberg, J. C.; Ramsey-Goldman, R.; Petri, M.; Reveille, J. D.; Vilá, L. M.; Merrill, J. T.; Tsao, B. P.; Kamen, D. L.; Gilkeson, G. S.; James, J. A.; Vyse, T. J.; International Consortium on the Genetics of Systemic Lupus Erythematosus; Gaffney, P. M.; Jacob, C. O.; Niewold, T. B.; Richardson, B. C.; Harley, J. B.; Alarcón-Riquelme, M. E.; Sawalha, A. H. Identification of novel genetic susceptibility loci in African American lupus patients in a candidate gene association study. Arthritis Rheum., 2011, 63, 3493-501.
73. Sanchez, E.; Nadig, A.; Richardson, B. C.; Freedman, B. I.; Kaufman, K. M.; Kelly, J. A.; Niewold, T. B.; Kamen, D. L.; Gilkeson, G. S.; Ziegler, J. T.; Langefeld, C. D.; Alarcón, G. S.; Edberg, J. C.; Ramsey-Goldman, R.; Petri, M.; Brown, E. E.; Kimberly, R. P.; Reveille, J. D.; Vilá, L. M.; Merrill, J. T.; Anaya, J. M.; James, J. A.; Pons-Estel, B. A.; Martin, J.; Park, S. Y.; Bang, S. Y.; Bae, S. C.; Moser, K. L.; Vyse, T. J.; Criswell, L. A.; Gaffney, P. M.; Tsao, B. P.; Jacob, C. O.; Harley, J. B.; Alarcón-Riquelme, M. E.; BIOLUPUS and GENLES, Sawalha, A. H. Phenotypic associations of genetic susceptibility loci in systemic lupus erythematosus. Ann. Rheum. Dis., 2011, 70, 1752-7.
74. Rajabi, P.; Alaee, M.; Mousavizadeh, K.; Samadikuchaksaraei, A. Altered Expression of TNFSF4 and TRAF2 mRNAs in Peripheral Blood Mononuclear Cells in Patients with Systemic Lupus Erythematosus: Association with Atherosclerotic Symptoms and Lupus Nephritis. Inflamm. Res., 2012, 61, 1347-54.
75. Stone, J. C. Regulation and Function of the RasGRP Family of Ras Activators in Blood Cells. Genes Can., 2011, 2, 320-34.
76. Coughlin, J. J.; Stang, S. L.; Dower, N. A; Stone, J. C. RasGRP1 and RasGRP3 Regulate B Cell Proliferation by Facilitating B Cell receptor-Ras Signaling. J. Immunol., 2005, 175, 7179-84.
77. Wang, C.; Ahlford, A.; Järvinen, T. M.; Nordmark, G.; Eloranta, M. L.; Gunnarsson, I.; Svenungsson, E.; Padyukov, L.; Sturfelt, G.; Jönsen, A.; Bengtsson, A. A.; Truedsson, L.; Eriksson, C.; Rantapää-Dahlqvist, S.; Sjöwall, C.; Julkunen, H.; Criswell, L. A.; Graham, R. R.; Behrens, T. W.; Kere, J.; Rönnblom, L.; Syvänen, A. C.; Sandling, J. K. Genes Identified in Asian SLE GWASs Are Also Associated with SLE in Caucasian Populations. Eur. J. Hum. Genet., 2012, 1-6.
78. He, C. F.; Liu, Y. S.; Cheng, Y. L.; Gao, J. P.; Pan, T. M.; Han, J. W.; Quan, C.; Sun, L. D.; Zheng, H. F.; Zuo, X. B.; Xu, S. X.; Sheng, Y. J.; Yao, S.; Hu, W. L.; Li, Y.; Yu, Z. Y.; Yin, X. Y.; Zhang, X. J.; Cui, Y.; Yang, S. TNIP1, SLC15A4, ETS1, RasGRP3 and IKZF1 Are Associated with Clinical Features of Systemic Lupus Erythematosus in a Chinese Han Population. Lupus, 2010, 19, 1181-6.
79. Yokoyama, K.; Su Ih, I.; Tezuka, T.; Yasuda, T.; Mikoshiba, K.; Tarakhovsky, A.; Yamamoto, T. BANK Regulates BCR-induced Calcium Mobilization by Promoting Tyrosine Phosphorylation of IP(3) Receptor. EMBO J., 2002, 21, 83-92.
80. Kurosaki, T. Regulation of B-cell Signal Transduction by Adaptor Proteins. Nat. Rev. Immunol., 2002, 354-63.
81. Castillejo-Lopez, C.; Delgado-Vega, A. M.; Wojcik, J.; Kozyrev, S. V.; Thavathiru, E.; Wu, Y. Y.; Sánchez, E.; Pöllmann, D.; López-Egido, J. R.; Fineschi, S.; Domínguez, N.; Lu, R.; James, J. A.; Merrill, J. T.; Kelly, J. A.; Kaufman, K. M.; Moser, K. L.; Gilkeson, G.; Frostegård, J.; Pons-Estel, B. A.; D'Alfonso, S.; Witte, T.; Callejas, J. L.; Harley, J. B.; Gaffney, P. M.; Martin, J.; Guthridge, J. M.; Alarcón-Riquelme, M.E. Genetic and physical interaction of the B-cell systemic lupus erythematosus-associated genes BANK1 and BLK. Ann. Rheum. Dis., 2012, 71, 136-142.
82. Kozyrev, S. V; Abelson, A. K.; Wojcik, J.; Zaghlool, A.; Linga Reddy, M. V.; Sanchez, E.; Gunnarsson, I.; Svenungsson, E.; Sturfelt, G.; Jönsen, A.; Truedsson, L.; Pons-Estel, B. A.; Witte, T.; D'Alfonso, S.; Barizzone, N.; Danieli, M. G.; Gutierrez, C.; Suarez, A.; Junker, P.; Laustrup, H.; González-Escribano, M. F.; Martin, J.; Abderrahim, H.; Alarcón-Riquelme, M. E. Functional Variants in the B-cell Gene BANK1 Are Associated with Systemic Lupus Erythematosus. Nat. Genet., 2008, 40, 211-6.
83. Sánchez, E.; Rasmussen, A.; Riba, L.; Acevedo-Vasquez, E.; Kelly, J. A.; Langefeld, C. D.; Williams, A. H.; Ziegler, J. T.; Comeau, M. E.; Marion, M. C.; García-De La Torre, I.; Maradiaga-Ceceña, M. A.; Cardiel, M. H.; Esquivel-Valerio, J. A.; Rodriguez-Amado, J.; Moctezuma, J. F.; Miranda, P.; Perandones, C. E.; Castel, C.; Laborde, H. A.; Alba, P.; Musuruana, J. L.; Goecke, I. A.; Anaya, J. M.; Kaufman, K. M.; Adler, A.; Glenn, S. B.; Brown, E. E.; Alarcón, G. S.; Kimberly, R. P.; Edberg, J. C.; Vilá, L. M.; Criswell, L. A.; Gilkeson, G. S.; Niewold, T. B.; Martín, J.; Vyse, T. J.; Boackle, S. A.; Ramsey-Goldman, R.; Scofield, R. H.; Petri, M.; Merrill, J. T.; Reveille, J. D.; Tsao, B. P.; Orozco, L.; Baca, V.; Moser, K. L.; Gaffney, P. M.; James, J. A.; Harley, J. B.; Tusié-Luna, T.; Pons-Estel, B. A.; Jacob, C. O.; Alarcón-Riquelme, M. E.; Impact of genetic ancestry and sociodemographic status on the clinical expression of systemic lupus erythematosus in American Indian-European populations. Arthritis Rheum. J., 2012, 11, 3687-3694.
84. Guan, M.; Yu, B.; Wan, J.; Zhang, X.; Wu, Z.; Zhong, Q.; Zhang, W.; Zou, H. Identification of BANK1 Polymorphisms by Unlabelled Probe High Resolution Melting: Association with Systemic Lupus Erythematosus Susceptibility and Autoantibody Production in Han Chinese. Rheumatology., 2011, 50, 473-80.
85. Järvinen, T. M.; Hellquist, A.; Zucchelli, M.; Koskenmies, S.; Panelius, J.; Hasan, T.; Julkunen, H.; D'Amato, M.; Kere, J. Replication of GWAS-identified Systemic Lupus Erythematosus Susceptibility Genes Affirms B-cell Receptor Pathway Signalling and Strengthens the Role of IRF5 in Disease Susceptibility in a Northern European Population. Rheumatology., 2012, 51, 87-92.
86. Suarez-Gestal, M.; Calaza, M.; Endreffy, E.; Pullmann, R.; Ordi-Ros, J.; Sebastiani, G. D.; Ruzickova, S.; Jose Santos, M.; Papasteriades, C.; Marchini, M.; Skopouli, F. N.; Suarez, A.; Blanco, F. J.; D'Alfonso, S.; Bijl, M.; Carreira, P.; Witte, T.; Migliaresi, S.; Gomez-Reino, J. J.; Gonzalez, A.; European Consortium of SLE DNA Collections. Replication of Recently Identified Systemic Lupus Erythematosus Genetic Associations: a Case-control Study. Arthritis Res. Ther., 2009, 11, R69.
87. Kozyrev, S. V.; Bernal-Quirós, M.; Alarcón-Riquelme, M. E.; Castillejo-López, C. The dual effect of the lupus-associated polymorphism rs10516487 on BANK1 gene expression and protein localization. Genes Immun. 2012, 13, 129-38.
88. Chung, S. A.; Taylor, K. E.; Graham, R. R.; Nititham, J.; Lee, A. T.; Ortmann, W. A.; Jacob, C. O.; Alarcón-Riquelme, M. E.; Tsao, B. P.; Harley, J. B.; Gaffney, P. M.; Moser, K. L.; SLEGEN; Petri, M.; Demirci, F. Y.; Kamboh, M. I.; Manzi, S.; Gregersen, P. K.; Langefeld, C. D.; Behrens, T. W.; Criswell, L. A. Differential Genetic Associations for Systemic Lupus Erythematosus Based on anti-dsDNA Autoantibody Production. PLoS Genet., 2011, 7, e1001323.
89. Wang, Y.; Zhu, J.; DeLuca, H.F. Where is the vitamin D receptor? Arch. Biochem. Biophys., 2012, 523, 123-133.
90. Uitterlinden, A. G.; Fang, Y.; Van Meurs, J. B.; Pols, H. A.; Van Leeuwen, J. P. Genetics and biology of vitamin D receptor polymorphisms. Gene, 2004, 2, 143-56.
91. Mory, D. B.; Rocco, E. R.; Miranda, W. L.; Kasamatsu, T.; Crispim, F.; Dib, S. A. Prevalence of Vitamin D Receptor Gene Polymorphisms FokI and BsmI in Brazilian Individuals with Type 1 Diabetes and Their Relation to Beta-cell Autoimmunity and to Remaining Beta-cell Function. Human Immun., 2009, 70, 447-51.
92. Luo, X. Y.; Wu, L. J.; Chen, L.; Yang, M. H.; Liao, T.; Liu, N. T.; Ku-Er, B.; Xie, C. M.; Shi, R. G.; Tang, Z.; Zhao, Y.; Zeng, X. F. Y. G. The Association of Vitamin D Receptor Gene ApaI and BsmI Polymorphism with Systemic Lupus Erythematosus. Zhonghua Nei. Ke. Za. Zhi., 2012, 51, 131-135.
93. Pani, M. A.; Knapp, M.; Donner, H.; Braun, J.; Baur, M. P.; Usadel, K. H.; Badenhoop, K. Vitamin D receptor allele combinations influence genetic susceptibility to type 1 diabetes in Germans. Diabetes, 2000, 49, 505-7.
94. Panierakis, C.; Goulielmos, G.; Mamoulakis, D.; Petraki, E.; Papavasiliou, E.; Galanakis, E. Vitamin D Receptor Gene Polymorphisms and Susceptibility to Type 1 Diabetes in Crete, Greece. Clin. Immunol., 2009, 133, 276-81.
95. Monticielo, O. A.; Teixeira, T. D. M.; Chies, J. A. B.; Brenol, J. C. T.; Xavier, R. M. Vitamin D and Polymorphisms of VDR Gene in Patients with Systemic Lupus Erythematosus. Clin. Rheum., 2012, 31, 1411-21.
96. Luo, X. Y.; Yang, M. H.; Wu, F. X.; Wu, L. J.; Chen, L.; Tang, Z.; Liu, N. T.; Zeng, X. F.; Guan, J. L.; Yuan, G. H. Vitamin D Receptor Gene BsmI Polymorphism B Allele, but Not BB Genotype, Is Associated with Systemic Lupus Erythematosus in a Han Chinese Population. Lupus, 2012, 21, 53-9.
97. Borchers, A. T.; Leibushor, N.; Naguwa, S. M.; Cheema, G. S.; Shoenfeld, Y.; Gershwin, M. E. Lupus Nephritis: A Critical Review. Autoimmun. Rev., 2012, 12, 174-194.
98. Li, P. H.; Wong, W. H.; Lee, T. L.; Lau, C. S.; Chan, T. M.; Leung, A. M.; Tong, K. L.; Tse, N. K.; Mo, k C. C.; Wong, S. N.; Lee, K. W.; Ho, M. H.; Lee, P. P.; Chong, C. Y.; Wong, R. W.; Mok, M. Y.; Ying, S. K.; Fung, S. K.; Lai, W. M.; Yang, W.; Lau, Y. L. Relationship Between Autoantibody Clustering and Clinical Subsets in SLE: Cluster and Association Analyses in Hong Kong Chinese. Rheum., 2012, 52, 337-45.
99. Mostowska, A.; Lianeri, M.; Wudarski, M.; Olesińska, M.; Jagodziński, P. P. Vitamin D Receptor Gene BsmI, FokI, ApaI and TaqI Polymorphisms and the Risk of Systemic Lupus Erythematosus. Mol. Biol. Rep., 2013, 40, 803-10.
100. De Azevêdo Silva, J.; Fernandes, K.M.; Pancotto, J.A.T.; Fragoso, T.S.; Donadi, E.A.; Crovella, C.; Sandrin-Garcia, P. Vitamin D receptor (VDR) gene Polymorphisms and Susceptibility to Systemic Lupus Erythematosus Clinical Manifestations. Lupus, 2013, 1,1110-7.
101. Chistiakov, D. A.; Turakulov, R. I. CTLA-4 and Its Role in Autoimmune Thyroid Disease. J. Mol. Endocrinol., 2003, 31, 21-36.
102. Kimkong, I.; Nakkuntod, J.; Sae-Ngow, S.; Snabboon, T.; Avihingsanon, Y.; Hirankarn, N. Association Between CTLA-4 Polymorphisms and the Susceptibility to Systemic Lupus Erythematosus and Graves' Disease in Thai Population. Asian Pac. J. Allergy Immunol., 2011, 29, 229-35.
103. Dariavach, P.; Mattéi, M. G.; Golstein, P.; Lefranc, M. P. Human Ig Superfamily CTLA-4 Gene: Chromosomal Localization and Identity of Protein Sequence Between Murine and Human CTLA-4 Cytoplasmic Domains. Eur. J. Immunol., 1988, 18, 1901-5.
104. Ulker, M.; Yazisiz, V.; Sallakci, N.; Avci, a B.; Sanlioglu, S.; Yegin, O.; Terzioglu, E. CTLA-4 Gene Polymorphism of Exon 1(+49 A/G) in Turkish Systemic Lupus Erythematosus Patients. Int. J. Immunogenet., 2009, 36, 245-50.
105. Sugimoto, K.; Fujita, S.; Yanagida, H.; Shimada, Y.; Tabata, N.; Yagi, K.; Okada, M.; Takemura, T. Clinical Manifestations and Analyses of the Cytotoxic T-lymphocyte Associated-4 Gene in Two Japanese Families with Systemic Lupus Erythematosus. Clin. Exp. Nephrol., 2008, 12, 149-54.
106. Ahmed, S.; Ihara, K.; Kanemitsu, S.; Nakashima, H.; Otsuka, T.; Tsuzaka, K.; Takeuchi, T.; Hara, T. Association of CTLA-4 but Not CD28 Gene Polymorphisms with Systemic Lupus Erythematosus in the Japanese Population. Rheum., 2001, 40, 662-7.
107. Bassi, C.; Xavier, D.J.; Palomino, G.; Nicolucci, P.; Soares, C.; Sakamoto-Hojo, E.; Donadi, E. Efficiency of the DNA Repair and Polymorphisms of the XRCC1, XRCC3 and XRCC4 DNA Repair Genes in Systemic Lupus Erythematosus. Lupus, 2008, 17, 988-95.
108. Takeda, Y.; Dynan, W.S. Autoantibodies Against DNA Double-Strand Break repair proteins. Front. Biosci., 2001, 6, 1412-1422.
109. Pavlovic, M.; Kats, A.; Cavallo, M.; Chen, R.; Hartmann, J. X.; Shoenfeld, Y. Pathogenic and Epiphenomenal Anti-DNA Antibodies in SLE. Autoimmune Dis., 2011, 2011, 462841. doi: 10.4061/2010/462841.
110. Davies, R. C.; Pettijohn, K.; Fike, F.; Wang, J.; Nahas, S. A; Tunuguntla, R.; Hu, H.; Gatti, R. a; McCurdy, D. Defective DNA Double-strand Break Repair in Pediatric Systemic Lupus Erythe matosus. Arthritis Rheum., 2012, 64, 568-78.
111. Warchoł, T.; Mostowska, A.; Lianeri, M.; La{ogonek}cki, J. K.; Jagodziński, P. P. XRCC1 Arg399Gln Gene Polymorphism and the Risk of Systemic Lupus Erythematosus in the Polish Population. DNA Cell Biol., 2012, 31, 50-6.
112. Lee, K. J.; Dong, X.; Wang, J.; Takeda, Y.; Dynan, W. S. Identification of Human Autoantibodies to the DNA Ligase IV/XRCC4 Complex and Mapping of an Autoimmune Epitope to a Potential Regulatory Region. J. Immunol., 2002, 169, 3413-21.
113. Lamerdin, J. E.; Montgomery, M. a; Stilwagen, S. A.; Scheidecker, L. K.; Tebbs, R. S.; Brookman, K. W.; Thompson, L. H.; Carrano, A.V. Genomic Sequence Comparison of the Human and Mouse XRCC1 DNA Repair Gene Regions. Genomics., 1995, 25, 547-54.
114. Lin, Y. J.; Wan, L.; Huang, C. M.; Chen, S. Y.; Huang, Y. C.; Lai, C. H.; Lin, W. Y.; Liu, H. P.; Wu, Y. S.; Chen, C. M.; Tsai, Y. H.; Tsai, C. H.; Sheu, J. J.; Tsai, F. J. Polymorphisms in the DNA Repair Gene XRCC1 and Associations with Systemic Lupus Erythematosus Risk in the Taiwanese Han Chinese Population. Lupus, 2009, 18, 1246-51.
115. Fasching, P. A.; Gayther, S.; Pearce, L.; Schildkraut, J. M.; Goode, E.; Thiel, F.; Chenevix-Trench, G.; Chang-Claude, J.; Wang-Gohrke, S.; Ramus, S.; Pharoah, P.; Berchuck, A.; OCAC (Ovarian Cancer Association Consortium). Role of genetic polymorphisms and ovarian cancer susceptibility. Mol. Oncol., 2009, 2, 171-81.
116. Tseng, R.C.; Hsieh, F.J.; Shih, C.M.; Hsu, H.S.; Chen, C.Y.; Wang, Y.C. Lung cancer susceptibility and prognosis associated with polymorphisms in the nonhomologous end-joining pathway genes: a multiple genotype-phenotype study. Cancer., 2009, 13, 2939-48.
117. Schildkraut, J.M.; Iversen, E.S.; Wilson, M.A.; Clyde, M.A.; Moorman, P.G.; Palmieri, R.T.; Whitaker, R.; Bentley, R.C.; Marks, J. R,; Berchuck, A. Association between DNA damage response and repair genes and risk of invasive serous ovarian cancer. PLoS One., 2010, 4, e10061.
118. De Azevêdo Silva, J.; Pancotto, J.A.T.; Donadi, E.A.; Crovella, C.; Sandrin-Garcia, P. LIG4 and RAD52 DNA repair genes polymorphisms and Systemic Lupus Erythematosus. Mol. Bio. Rep., 2013, 1, 0.
119. Fonseca, A.M.S.; Pancotto, J.A. T; Donadi, E.A.; Segat, L.; Crovella, S.; Sandrin-Garcia, P. Polymorphisms in STK17A gene are associated to Systemic Lupus Erythematosus and its Clinical Manifestations. Gene, 2013, 2, 435-9.
120. Sanjo, H.; Kawai, T.; Akira, S. DRAKs, Novel Serine/threonine Kinases Related to Death-associated Protein Kinase That Trigger Apoptosis. J. Biol. Chem., 1998, 273, 29066-71.
121. Mao, P.; Hever, M. P.; Niemaszyk, L. M.; Haghkerdar, J. M.; Yanco, E. G.; Desai, D.; Beyrouthy, M. J.; Kerley-Hamilton, J. S.; Freemantle, S. J.; Spinella, M. J. Serine/threonine Kinase 17A Is a Novel P53 Target Gene and Modulator of Cisplatin Toxicity and Reactive Oxygen Species in Testicular Cancer Cells. J. Biol. Chem., 2011, 286, 19381-91.
122. Ding, Q.; Reddy, Y. V. R.; Wang, W.; Woods, T.; Douglas, P.; Ramsden, D. A.; Lees-miller, S. P.; Meek, K. Autophosphorylation of the Catalytic Subunit of the DNA-Dependent Protein Kinase is Required for Efficient End Processing During DNA Double-Strand Break Repair. Mol. Cell. Biol., 2003, 5836-48.
123. Ohnishi, T.; Mori, E.; Takahashi, A. DNA Double-strand Breaks: Their Production, Recognition, and Repair in Eukaryotes. Mutation Res., 2009, 669, 8-12.
124. Baechler, E. C.; Batliwalla, F. M.; Karypis, G.; Gaffney, P. M.; Ortmann, W. A; Espe, K. J.; Shark, K. B.; Grande, W. J.; Hughes, K. M.; Kapur, V.; Gregersen P.K.; Behrens, T.W. Interferoninducible Gene Expression Signature in Peripheral Blood Cells of Patients with Severe Lupus. Proc. Natl. Acad. Sci. U.S.A., 2003, 100, 2610-5.
125. Bengtsson, A.; Sturfelt, G.; Truedsson, L.; Blomberg, J.; Alm, G.; Vallin, H.; Rönnblom, L. Activation of Type I Interferon System in Systemic Lupus Erythematosus Correlates with Disease Activity but Not with Antiretroviral Antibodies. Lupus, 2000, 9, 664-671.
126. Rönnblom, L.; Alm, G. V; Eloranta, M.-L. The Type I Interferon System in the Development of Lupus. Sem. Immunol., 2011, 23, 113-21.
127. Salloum, R.; Niewold, T. B. Interferon Regulatory Factors in Human Lupus Pathogenesis. Transl. Res., 2011, 157, 326-31.
128. Chistiakov, D. A. Interferon Induced with Helicase C Domain 1 (IFIH1) and Virus-induced Autoimmunity: a Review. Vir. Immunol., 2010, 23, 3-15.
129. Lenert, P. Nucleic Acid Sensing Receptors in Systemic Lupus Erythematosus: Development of Novel DNA-And/or RNA-like Analogues for Treating Lupus. Clin. Exp. Immunol., 2010, 161, 208-22.
130. Cunninghame Graham, D. S.; Morris, D. L.; Bhangale, T. R.; Criswell, L. A.; Syvänen, A.-C.; Rönnblom, L.; Behrens, T. W.; Graham, R. R.; Vyse, T. J. Association of NCF2, IKZF1, IRF8, IFIH1, and TYK2 with Systemic Lupus Erythematosus. PLoS Genetics, 2011, 7, e1002341.
131. Cen, H.; Leng, R.; Wang, W.; Zhou, M.; Feng, C.; Zhu, Y.; Yang, X.; Yang, M.; Zhai, Y.; Li, B.; Liu, J.; Pan, H.F.; Ye, D.Q. Association Study of IFIH1 rs1990760 Polymorphism with Systemic Lupus Erythematosus in a Chinese Population. Inflammation, 2013, 2, 444-48.
132. Moura, R.; De Azevêdo Silva, J.; Pancotto, J. A.T.; Donadi, E.A.; Brandão, L.A.C.; Crovella, S.; Sandrin-Garcia, P. Interferon-Induced with Helicase C Domain 1 (IFIH1) gene polymorphisms and meta-analysis study in Systemic Lupus Erythematosus. J. Mol. Biol. Rep., 2013, 1.
133. Kawasaki, A.; Kyogoku, C.; Ohashi, J.; Miyashita, R.; Hikami, K.; Kusaoi, M.; Tokunaga, K.; Takasaki, Y.; Hashimoto, H.; Behrens, T. W.; Tsuchiya, N. Association of IRF5 Polymorphisms with Systemic Lupus Erythematosus in a Japanese Population: Support for a Crucial Role of Intron 1 Polymorphisms. Arthritis Rheum., 2008, 58, 826-34.
134. Cham, C. M.; Ko, K.; Niewold, T. B. Interferon Regulatory Factor 5 in the Pathogenesis of Systemic Lupus Erythematosus. Clin. Dev. Immunol., 2012, 2012, 780436.
135. Alarcón-Riquelme, M. E.; Prokunina, L. Finding Genes for SLE: Complex Interactions and Complex Populations, Journal of Autoimmunity. J. Autoimmun., 2003, 21, 117-120.
136. Sigurdsson, S.; Nordmark, G.; Göring, H. H. H.; Lindroos, K.; Wiman, A.-C.; Sturfelt, G.; Jönsen, A.; Rantapää-Dahlqvist, S.; Möller, B.; Kere, J.; Koskenmies, S.; Widén, E.; Eloranta, M.L.; Julkunen, H.; Kristjansdottir, H.; Steinsson, K.; Alm, G.; Rönnblom, L.; Syvänen, A.C. Polymorphisms in the Tyrosine Kinase 2 and Interferon Regulatory Factor 5 Genes Are Associated with Systemic Lupus Erythematosus. J. Hum. Genet., 2005, 76, 528-37.
137. Graham, R. R.; Hom, G.; Ortmann, W.; Behrens, T. W. Review of Recent Genome-wide Association Scans in Lupus. J. Int. Med., 2009, 265, 680-8.
138. Stone, R. C.; Du, P.; Feng, D.; Dhawan, K.; Rönnblom, L.; Eloranta, M.-L.; Donnelly, R.; Barnes, B. J. RNA-Seq for Enrichment and Analysis of IRF5 Transcript Expression in SLE. PloS One, 2013, 8, e54487.
139. Cherian, T. S.; Kariuki, S. N.; Franek, B. S.; Buyon, J. P.; Clancy, R. M.; Niewold, T. B. Brief Report: IRF5 Systemic Lupus Erythematosus Risk Haplotype Is Associated with Asymptomatic Serologic Autoimmunity and Progression to Clinical Autoimmunity in Mothers of Children with Neonatal Lupus. Arthritis Rheum., 2012, 64, 3383-7.
140. Niewold, T. B.; Adler, J. E.; Glenn, S. B.; Lehman, T. J. A.; Harley, J. B.; Crow, M. K. Age-and Sex-Related Patterns of Serum Interferon-α Activity in Lupus Families. Arthritis Rheum., 2009, 58, 2113-2119.
141. Ntali, S.; Karim, M. Y. Autoantibodies as Markers for Detecting Concurrent Disease Activity in Systemic Lupus Erythematosus. Transl. Res., 2010, 156, 317-9.
142. Qin, L.; Lv, J.; Zhou, X.; Hou, P.; Yang, H.; Zhang, H. Association of IRF5 Gene Polymorphisms and Lupus Nephritis in a Chinese Population. Nephrol., 2010, 15, 710-3.
143. Järvinen, T. M.; Hellquist, A.; Koskenmies, S.; Einarsdottir, E.; Koskinen, L. L. E.; Jeskanen, L.; Berglind, L.; Panelius, J.; Hasan, T.; Ranki, A.; Kere, J.; Saarialho-Kere, U. Tyrosine Kinase 2 and Interferon Regulatory Factor 5 Polymorphisms Are Associated with Discoid and Subacute Cutaneous Lupus Erythematosus. Exp. Dermatol., 2010, 19, 123-31.
144. Lee, Y. H.; Choi, S. J.; Ji, J. D.; Song, G. G. Associations Between PXK and TYK2 Polymorphisms and Systemic Lupus Erythematosus: a Meta-analysis. Inflamm. Res., 2012, 61, 949-54.
145. Kyogoku, C.; Morinobu, A.; Nishimura, K.; Sugiyama, D.; Hashimoto, H.; Tokano, Y.; Mimori, T.; Terao, C.; Matsuda, F.; Kuno, T. Kumagai, S. Lack of Association Between Tyrosine Kinase 2 (TYK2) Gene Polymorphisms and Susceptibility to SLE in a Japanese Population. Mod. Rheumatol., 2009, 19, 401-6.
146. Li, P.; Chang, Y. U. K. K.; Shek, K. A. W. A. I.; Lau, Y. U. L. Lack of Association of TYK2 Gene Polymorphisms in Chinese Patients with Systemic Lupus Erythematosus. J. Rheumatol., 2011, 38, 1-3.
147. Dos Santos, B. P.; Valverde, J. V; Rohr, P.; Monticielo, O. A.; Brenol, J. C. T.; Xavier, R. M.; Chies, J. A. B. TLR7/8/9 Polymorphisms and Their Associations in Systemic Lupus Erythematosus Patients from Southern Brazil. Lupus, 2012, 21, 302-9.
148. Xu, Y.; Fan, H.; Li, X.; Sun, L.; Hou, Y. 17β-Estradiol Enhances Response of Mice Spleen B Cells Elicited by TLR9 Agonist. Cell. Immunol., 2012, 278, 125-35.
149. Haas, T.; Metzger, J.; Schmitz, F.; Heit, A.; Müller, T.; Latz, E.; Wagner, H. The DNA Sugar Backbone 2' Deoxyribose Determines Toll-like Receptor 9 Activation. Immun., 2008, 28, 315-23.
150. Møller-Larsen, S.; Nyegaard, M.; Haagerup, A.; Vestbo, J.; Kruse, T. A.; Børglum, A. D. Association Analysis Identifies TLR7 and TLR8 as Novel Risk Genes in Asthma and Related Disorders. Thorax, 2008, 63, 1064-9.
151. Lazarus, R.; Klimecki, W. T.; Raby, B. A.; Vercelli, D.; Palmer, L. J.; Kwiatkowski, D. J.; Silverman, E. K.; Martinez, F.; Weiss, S. T. Single-nucleotide Polymorphisms in the Toll-like Receptor 9 Gene (TLR9): Frequencies, Pairwise Linkage Disequilibrium, and Haplotypes in Three U.S. Ethnic Groups and Exploratory Case-control Disease Association studies. Genomics, 2003, 81, 85-91.
152. Gantier, M. P.; Irving, A. T.; Kaparakis-Liaskos, M.; Xu, D.; Evans, V. A.; Cameron, P. U.; Bourne, J. A.; Ferrero, R. L.; John, M.; Behlke, M. A. Williams, B.R. Genetic Modulation of TLR8 Response Following Bacterial Phagocytosis. Hum. Mutation, 2010, 31, 1069-79.
153. Papadimitraki, E. D.; Tzardi, M.; Bertsias, G.; Sotsiou, E.; Boumpas, D. T. Glomerular Expression of Toll-like Receptor-9 in Lupus Nephritis but Not in Normal Kidneys: Implications for the Amplification of the Inflammatory Response. Lupus, 2009, 18, 831-5.
154. Conti, F.; Spinelli, F. R.; Alessandri, C.; Valesini, G. Toll-like Receptors and Lupus Nephritis. Clin. Rev. Allerg. Immu., 2011, 40, 192-8.
155. Piotrowski, P.; Lianeri, M.; Wudarski, M.; Olesińska, M.; Jagodziński, P. P. Contribution of STAT4 Gene Single-nucleotide Polymorphism to Systemic Lupus Erythematosus in the Polish Population. Mol. Biol. Rep., 2012, 39, 8861-6.
156. Jacob, C. O.; Zang, S.; Li, L.; Ciobanu, V.; Mizutani, A.; Satoh, M.; Koss, M.; Quismorio, F. Pivotal role of Stat4 and Stat6 in the pathogenesis of the lupus-like disease in the New Zealand mixed 2328 mice. J. Immunol., 2003 171,1564-71.
157. Remmers, E. F.; Plenge, R. M.; Lee, A. T.; Graham, R. R.; Hom, G.; Behrens, T. W.; Bakker, P. I. W. de; Le, J. M.; Lee, H.-S.; Batliwalla, F.; Li, W.; Masters, S.L.; Booty, M.G.; Carulli, J.P.; Padyukov, L.; Alfredsson, L.; Klareskog, L.; Chen, W.V.; Amos, C.I.; Criswell, L.A.; Seldin, M.F.; Kastner, D.L.; Gregersen, P.K. STAT4 and the Risk of Rheumatoid Arthritis and Systemic Lupus Erythematosus. N. Engl. J. Med., 2007, 357, 977-86.
158. Zheng, J.; Yin, J.; Huang, R.; Petersen, F.; Yu, X. Meta-analysis Reveals an Association of STAT4 Polymorphisms with Systemic Autoimmune Disorders and anti-dsDNA Antibody. Hum. Immunol., 2013, 74: 986-92.
159. Taylor, K. E.; Remmers, E. F.; Lee, A. T.; Ortmann, W. A.; Plenge, R. M.; Tian, C.; Chung, S. a; Nititham, J.; Hom, G.; Kao, A. H. Demirci, F.Y.; Kamboh, M.I.; Petri, M.; Manzi, S.; Kastner, D.L.; Seldin, M.F.; Gregersen, P.K.; Behrens, T.W.; Criswell, L.A. Specificity of the STAT4 Genetic Association for Severe Disease Manifestations of Systemic Lupus Erythematosus. PLoS Genet., 2008, 4, e1000084.